Clinical Trial Update: Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating changes in cerebral glucose metabolism after 12 weeks of paroxetine treatment in patients with panic disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Samsung Medical Center | Conditions: Panic Disorder | Phase 4 | Status: COMPLETED